Compare EMAT & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EMAT | XENE |
|---|---|---|
| Founded | N/A | 1996 |
| Country | United States | Canada |
| Employees | N/A | 370 |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.7B | 5.2B |
| IPO Year | N/A | 2014 |
| Metric | EMAT | XENE |
|---|---|---|
| Price | $7.86 | $54.28 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 11 |
| Target Price | $30.00 | ★ $68.55 |
| AVG Volume (30 Days) | 100.7K | ★ 823.1K |
| Earning Date | 05-18-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $311,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2,122.43 | $2,496.48 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $5.50 | $28.19 |
| 52 Week High | $17.50 | $62.91 |
| Indicator | EMAT | XENE |
|---|---|---|
| Relative Strength Index (RSI) | 43.86 | 44.13 |
| Support Level | $6.93 | $52.92 |
| Resistance Level | $8.14 | $59.43 |
| Average True Range (ATR) | 0.99 | 1.59 |
| MACD | -0.21 | -0.28 |
| Stochastic Oscillator | 26.22 | 24.15 |
Evolution Metals & Technologies Corp is a critical materials and technology company. The company is focused on developing a secure, dependable, and self-sustaining U.S.-aligned supply chain for critical minerals and materials (CMM), and rare earth elements (REEs). The company is also engaged in recycling end-of-life materials through urban mining to help strengthen domestic resource independence and long-term supply stability.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.